2-phenylquinoline has been researched along with Infections, Staphylococcal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astolfi, A; Barreca, ML; Felicetti, T; Moro, S; Palazzotti, D; Sabatini, S; Sturlese, M | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Felicetti, T; Kaatz, GW; Kieć-Kononowicz, K; Latacz, G; Lubelska, A; Manfroni, G; Massari, S; Pietrella, D; Sabatini, S; Schindler, BD; Tabarrini, O | 1 |
2 other study(ies) available for 2-phenylquinoline and Infections, Staphylococcal
| Article | Year |
|---|---|
Fighting Antimicrobial Resistance: Insights on How the
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cryoelectron Microscopy; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Staphylococcal Infections; Staphylococcus aureus | 2023 |
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Tissue Distribution | 2018 |